SAN DIEGO– Illumina, Inc. (NASDAQ: ILMN) announced today that a federal jury in Wilmington, Delaware, found that certain of Illumina’s TruSeq sample preparation and cluster generation kits and products infringe U.S. Patent No. 6,107,023, owned by LadaTech LLC, a patent holding company. Other Illumina sample preparation kits, such as its Nextera kits, were not accused […]
MOUNTAIN VIEW, Calif. – Complete Genomics Inc., the whole human genome sequencing company, today announced the formation of its Genomic Medicine Advisory Board (GMAB). The GMAB will provide insight and guidance on the best ways for the company to provide sequencing services to healthcare organizations and physicians interested in implementing genomic medicine in their practice. […]
SANTA CLARA, Calif., and SHENZHEN, China, Agilent Technologies Inc. (NYSE: A) and BGI today announced a collaborative effort to develop methodologies designated for next-generation genome-wide association studies. The methodologies will assist scientists pursuing disease and drug research. The goal of the collaboration is to create a next-generation super exome, using Agilent’s SureSelect technology. The super […]
Roche announced today that it has extended its cash tender offer to acquire all outstanding shares of Illumina, Inc., at a price of $44.50 per share, to 6:00 p.m., New York City time, on March 23, 2012. The tender offer was previously scheduled to expire at 12:00 midnight, New York City time, at the end […]
Fluidigm Corporation unveiled a new custom assay design service for high-sample throughput amplicon resequencing on Illumina platforms at the recent Advances in Genome Biology and Technology (AGBT) meeting. The Access Array™ Target-Specific Primers, when used with the Fluidigm Access Array System, allow for fast, simple, and inexpensive preparation of up to 480 amplicons per sample […]
SAN DIEGO -Illumina, Inc., a leading developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and function, today issued the following statement regarding Roche’s decision to extend its unsolicited tender offer to acquire all outstanding shares of Illumina for $44.50 in cash per common share: “The extension […]
MOUNTAIN VIEW, Calif. – Complete Genomics, Inc. (NASDAQ: GNOM) announced today that the journal Nature has published a neuroblastoma study conducted using the company’s high-depth whole human genome sequencing service. The company believes that this is not only the most comprehensive genomic analysis of neuroblastoma published to date, but also the largest whole-genome survey of […]
WESTBOROUGH, Mass., GenomeQuest Inc., a global provider of large-scale genomic software applications, today introduced new enhancements to its GQ-Dx genomic decision support system that enables molecular laboratories to produce routine, actionable diagnostic reports from next generation sequencing (NGS) runs. Highlighted by a proprietary genomic knowledge engine, GQ-Dx 2.0 transforms NGS diagnostics from slow, labor-intensive odysseys […]
Complete Genomics Co-Authors Paper Demonstrating Impact of Hepatitis B Virus on Liver Cancer Genomes
MOUNTAIN VIEW, Calif. – Complete Genomics Inc. (NASDAQ: GNOM) announced today that Genome Research has published a paper it co-authored describing the effects of hepatitis B virus (HBV) integration into the genomes of liver cancer patients. HBV infection is a recognized risk factor for the development of liver cancer. The paper, co-authored with researchers at […]
Oxford, UK/FL, US. Oxford Nanopore Technologies Ltd. today presented for the first time DNA sequence data using its novel nanopore ‘strand sequencing’ technique and proprietary high performance electronic devices GridION and MinION. These data were presented by Clive G Brown, Chief Technology Officer, who outlined the Company’s pathway to a commercial product with highly disruptive […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
